Combined Grey Matter VBM and White Matter TBSS Analysis in Young First Episode Psychosis Patients With and Without Cannabis Consumption

Potential Protective Effects of Cannabidiol on Neuroanatomical Alterations in Cannabis Users and Psychosis: A Critical Review

(2012) Derik Hermann et al.   CURRENT PHARMACEUTICAL DESIGN

Effects of Cannabis Use on Human Brain Structure in Psychosis: A Systematic Review Combining In Vivo Structural Neuroimaging and Post Mortem Studies

(2012) Charlotte Rapp et al.   CURRENT PHARMACEUTICAL DESIGN

Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence

(2012) Berend Malchow et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Increased gray matter density in patients with schizophrenia and cannabis use: A voxel-based morphometric study using DARTEL

(2012) Thomas Schnell et al.   SCHIZOPHRENIA RESEARCH

Greater white and grey matter changes associated with early cannabis use in adolescent-onset schizophrenia (AOS)

(2011) A. James et al.   SCHIZOPHRENIA RESEARCH

Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia

(2011) Beng-Choon Ho et al.   SCHIZOPHRENIA RESEARCH

Reduced Cortical Thickness as an Outcome of Differential Sensitivity to Environmental Risks in Schizophrenia

(2010) Petra Habets et al.   BIOLOGICAL PSYCHIATRY

Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia

(2010) Monica Rais et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Neuroanatomy of vulnerability to psychosis: A voxel-based meta-analysis

(2010) P. Fusar-Poli et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

High-potency cannabis and the risk of psychosis

(2009) Marta Di Forti et al.   BRITISH JOURNAL OF PSYCHIATRY

Recent diffusion tensor imaging findings in early stages of schizophrenia

(2009) Marinos Kyriakopoulos et al.   CURRENT OPINION IN PSYCHIATRY

The Effects of Antipsychotics on the Brain: What Have We Learnt from Structural Imaging of Schizophrenia? – A Systematic Review

(2009) R. Smieskova et al.   CURRENT PHARMACEUTICAL DESIGN

Comorbid substance abuse and brain morphology in recent-onset psychosis

(2009) Thomas Wobrock et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Cannabis use and callosal white matter structure and integrity in recent-onset schizophrenia

(2009) Nienke Dekker et al.   PSYCHIATRY RESEARCH-NEUROIMAGING

Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings

(2009) S. Navari et al.   PSYCHOLOGICAL MEDICINE

Neuroimaging in cannabis use: a systematic review of the literature

(2009) R. Martín-Santos et al.   PSYCHOLOGICAL MEDICINE

Mapping grey matter reductions in schizophrenia: An anatomical likelihood estimation analysis of voxel-based morphometry studies

(2009) A. Fornito et al.   SCHIZOPHRENIA RESEARCH

Excessive Brain Volume Loss Over Time in Cannabis-Using First-Episode Schizophrenia Patients

(2008) Monica Rais et al.   AMERICAN JOURNAL OF PSYCHIATRY

Meta-Analysis of Gray Matter Anomalies in Schizophrenia: Application of Anatomic Likelihood Estimation and Network Analysis

(2008) David C. Glahn et al.   BIOLOGICAL PSYCHIATRY

Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference

(2008) S SMITH et al.   NEUROIMAGE

Cannabis use and brain structural alterations in first episode schizophrenia — A region of interest, voxel based morphometric study

(2008) Srihari S. Bangalore et al.   SCHIZOPHRENIA RESEARCH